Cairn Homes plc Issue of Equity for Vesting of RSU's (5236X)

TIDMCRN

RNS Number : 5236X

Cairn Homes plc

04 May 2021

Cairn Homes plc

("Cairn" or the "Company")

Issue of Equity for Vesting of Restricted Share Units under the Cairn Homes plc Restricted Share Unit Plan

Dublin/London, 4 May 2021: Cairn Homes plc, the leading Irish homebuilding company, announces that the Company has applied for a block listing of 1,657,361 new ordinary shares of EUR0.001 each in the Company (the "Ordinary Shares") pursuant to the vesting of restricted share units by a number of employees under the Cairn Homes plc Restricted Share Unit Plan.

Application has been made for the new Ordinary Shares to be admitted to trading on the Official List of Euronext Dublin and to the Official List of the UK Listing Authority and it is expected that admission will take place on 7 May 2021. The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following this admission, the total issued share capital of the Company will increase to 751,107,490 ordinary shares.

-ENDS-

For further information, contact:

Cairn Homes plc [phone]

Tara Grimley, Company Secretary

Notes to Editors

Cairn Homes plc ("Cairn") is the leading Irish homebuilder committed to building high-quality, competitively-priced, sustainable new homes in great locations. At Cairn, the homeowner is at the very centre of the design process and we strive to provide an unparalleled customer service throughout each stage of the home-buying journey. A new Cairn home is thoughtfully designed and built to last with a focus on creating shared spaces and environments where communities prosper. Cairn owns a c. 16,800 unit land bank across 36 residential development sites, over 90% of which are located in the Greater Dublin Area ("GDA") with excellent public transport and infrastructure links.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEUSSVRAOUVRAR

(END) Dow Jones Newswires

May 04, 2021 11:45 ET (15:45 GMT)